Get started
Live feed
·
PRReleasevia Quantisnow
Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Announces Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Milestone Pharmaceuticals Inc. logo
MIST
Milestone Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2019
Get push alerts for MIST

Follow MIST and get a push notification the moment its next story breaks.

Full MIST profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MIST (Milestone Pharmaceuticals Inc.) and more on Quantisnow.